Francis Nelson Shen Buys 50,000 Shares of Vitalhub (TSE:VHI) Stock

Vitalhub Corp. (TSE:VHI) Director Francis Nelson Shen purchased 50,000 shares of the stock in a transaction on Thursday, March 26th. The shares were bought at an average price of C$6.99 per share, for a total transaction of C$349,500.00. Following the acquisition, the director owned 50,000 shares of the company’s stock, valued at approximately C$349,500. The trade was a ∞ increase in their ownership of the stock.

Francis Nelson Shen also recently made the following trade(s):

• On Tuesday, March 24th, Francis Nelson Shen acquired 439,600 shares of Vitalhub stock. The stock was purchased at an average price of C$7.00 per share, with a total value of C$3,077,200.00.

Vitalhub Trading Down 0.4%

Shares of Vitalhub stock opened at C$6.95 on Friday. The firm has a fifty day simple moving average of C$8.07 and a 200-day simple moving average of C$9.30. The stock has a market capitalization of C$439.46 million, a price-to-earnings ratio of 69.50, a PEG ratio of 1.18 and a beta of 0.65. Vitalhub Corp. has a 1-year low of C$6.67 and a 1-year high of C$14.64.

Vitalhub (TSE:VHI) last posted its earnings results on Wednesday, March 18th. The company reported C$0.06 earnings per share (EPS) for the quarter. The business had revenue of C$31.39 million for the quarter. Vitalhub had a net margin of 5.61% and a return on equity of 2.75%. As a group, research analysts predict that Vitalhub Corp. will post 0.2296467 earnings per share for the current year.

Analyst Upgrades and Downgrades

VHI has been the topic of a number of research analyst reports. Raymond James Financial lowered their target price on Vitalhub from C$15.00 to C$11.00 and set an “outperform” rating on the stock in a report on Tuesday, March 24th. Royal Bank Of Canada cut their price target on Vitalhub from C$13.00 to C$12.00 and set an “outperform” rating for the company in a report on Monday, January 26th. Scotiabank reduced their price objective on Vitalhub from C$15.00 to C$12.00 and set an “outperform” rating for the company in a research report on Wednesday, February 4th. Finally, ATB Cormark Capital Markets lowered their price objective on shares of Vitalhub from C$16.50 to C$15.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 10th. One equities research analyst has rated the stock with a Strong Buy rating and six have issued a Buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of C$13.86.

About Vitalhub

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.